• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    NeuroMetrix Inc. (NURO)

    -NasdaqCM
    1.75 Up 0.08(4.99%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:1.67
    Open:1.70
    Bid:1.50 x 2000
    Ask:4.50 x 1000
    1y Target Est:6.30
    Beta:0.7
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:1.60 - 1.75
    52wk Range:1.52 - 3.15
    Volume:122,774
    Avg Vol (3m):71,708
    Market Cap:14.14M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NURO

    Comparison

    Symbol% ChgMkt Cap
    NUROUp 4.99%14.14M
    CFNDown 0.12%12.28B
    MDTDown 1.01%76.77B
    BABYDown 2.52%1.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.44
    Ex-Dividend Date:28-Mar-07

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback